Leidos awarded Medicaid Enterprise Systems Integrator contract
Get Alerts LDOS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.4%
EPS Growth %: -10.0%
Join SI Premium – FREE
"Transitioning North Dakota's legacy Medicaid systems to a modern system will help provide a better healthcare experience for patients, providers and administrators," said
Leidos will support
To learn more, read about Leidos' Medicaid systems solutions or visit www.leidos.com/civilian-health.
About Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 47,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in
Certain statements in this announcement constitute "forward-looking statements" within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management's current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the "Risk Factors" set forth in Leidos' Annual Report on Form 10-K for the fiscal year ended
Contact:
Melissa Dueñas
(571) 526-6850
[email protected]
(571) 526-6743
[email protected]
(571) 526-6257
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/leidos-awarded-medicaid-enterprise-systems-integrator-contract-302191078.html
SOURCE Leidos Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sun Life warns shareholders of Ocehan LLC's below-market mini-tender offer
- IES Holdings (IESC) files mixed shelf
- Enanta Pharmaceuticals sets up $75M at-the-market stock offering
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share